Skip to main navigation Skip to search Skip to main content

Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer

  • Hidenori Kitai
  • , Philip H. Choi
  • , Yu C. Yang
  • , Jacob A. Boyer
  • , Adele Whaley
  • , Priya Pancholi
  • , Claire Thant
  • , Jason Reiter
  • , Kevin Chen
  • , Vladimir Markov
  • , Hirokazu Taniguchi
  • , Rui Yamaguchi
  • , Hiromichi Ebi
  • , James Evans
  • , Jingjing Jiang
  • , Bianca Lee
  • , David Wildes
  • , Elisa de Stanchina
  • , Jacqueline A.M. Smith
  • , Mallika Singh
  • Neal Rosen

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases